Insilico Medicine reviews

(1) My senior management only focuses on personal benefit. Frankly speaking, you’re not competing with the people working around you; ISM is competing with the world! Please stop complaining about and gossiping about other colleagues 24/7. Those senior directors and scientists have their positions for a reason, and it’s unfair to compare "your work" with theirs, as you may not know everything they’ve accomplished. (2) Honestly but sadly, my senior management has limited scientific and business knowledge but yet still claim to have made "significant contributions to target discovery" and to recognized as "a key opinion leader in respective domain" according to my senior management's statement. To be frank, you’re using software created by others for target discovery, and while you benefit from it, you still complain about the software developers?

- High Turnover: 100% turnover in Hong Kong R&D team and 80% in the publication team for FY2024 (excluding senior management). - Lack of knowledge: Senior management in HK lacks basic scientific and medical knowledge (e.g., first-line therapy, drug classes). - Confidentiality Issues: HK senior management inappropriately disclosed employees’ appraisal content and confidential information to other employees. False statements about employees have been made to teammates, aimed at misleading colleagues and damaging reputations, which undermines morale and creates a toxic work enviroment. - Stagnation: No new local R&D projects in HK for FY2024; no opportunities for developing and learning.